Vivo Capital’s New Frontier Health Corporation Ordinary Shares NFH Stock Holding History

Vivo Capital’s Portfolio NFH Stock Details NFH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14,300,000	Closed	-$171M	–	55
2022 Q1	$171M	Hold	14,300,000	–	–	11.77%	2
2021 Q4	$164M	Hold	14,300,000	–	–	9.88%	3
2021 Q3	$161M	Hold	14,300,000	–	–	7.21%	4
2021 Q2	$160M	Hold	14,300,000	–	–	6.91%	5
2021 Q1	$162M	Hold	14,300,000	–	–	5.68%	5
2020 Q4	$123M	Hold	14,300,000	–	–	5.49%	5
2020 Q3	$109M	Hold	14,300,000	–	–	6.31%	4
2020 Q2	$118M	Hold	14,300,000	–	–	8.49%	3
2020 Q1	$118M	Buy	+14,300,000	New	+$130M	10.69%	2

Vivo Capital's NFH Position: Q2 2022 in Review

Vivo Capital sold out of New Frontier Health Corporation Ordinary Shares (NFH) in Q2 2022, closing a stake of 14,300,000 shares — an estimated $171M sold.

Vivo Capital first reported a position in NFH in Q1 2020 and held it in 9 quarters. The position peaked at $171M in Q1 2022. 0 funds tracked by Wall St. Rank hold NFH as of Q2 2022.

Vivo Capital reported no remaining New Frontier Health Corporation Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Vivo Capital sold 14,300,000 New Frontier Health Corporation Ordinary Shares shares in Q2 2022, an estimated $171M.
Vivo Capital first reported a position in New Frontier Health Corporation Ordinary Shares in Q1 2020 and held it in 9 quarters.
Vivo Capital's New Frontier Health Corporation Ordinary Shares position peaked at $171M in Q1 2022.
0 funds tracked by Wall St. Rank held New Frontier Health Corporation Ordinary Shares as of Q2 2022.

Based on Vivo Capital's 13F filing for Q2 2022, filed 15 Aug 2022.